NEW YORK, May 4, 2017 /PRNewswire/ -- According to Stratistics MRC, the global Pneumonia Diagnostic market is accounted for $xx million in 2016 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2016 to 2022. Read the full report: http://www.reportlinker.com/p04823110/Pneumonia-Diagnostic-Global-Market-Outlook.htmlFactors such as developing innovative technologies and products, increasing patient awareness and improving productivity of diagnosing pneumonia are boosting the market growth. Advent of new drugs and advance treatment facilitates are going to provide new market opportunities to emerge. However, there is no particular treatment available to detect the pneumonia as its symptoms coincide with diseases like bronchitis, common cold and asthma which are restraining the market growth. Chest X-ray and CT scan are generally recommended for the diagnosis of pneumonia diagnostics. North America is the largest market due to increasing resistance to multi drugs by microorganisms and increasing geriatric population. Asia Pacific is anticipated to be the fastest growing market owing to prevalence of disease in several countries including India, Japan and Bangladesh. Additionally, high awareness and disposable income are potential growth factors. Some of the key players in global Pneumonia Diagnostic market are Abbott, Affymetrix, Beckman Coulter Inc, Becton Dickinson, BioMerieux, Bio-Rad, Cepheid, Diamedix, Elitech Group, Qiagen, Siemens, Thermo Fisher Scientific, GlaxoSmithCline and Merck & Co. Treatments Covered:
- Vaccines o PCV13 o PPV23 - Antibiotics o Amoxicillin o Cephalosporin o Penicillin o Tetracycline o Vancomycin o Fluoroquinolones Tests Covered:
- Blood Test - Bronchoscopy - Chest X ray - Chest Computed Tomography (CT) Scan - Pulse Oximetry - Pleural Fluid Culture - Sputum Test End Users Covered:
- Clinics - Diagnostic Centres - Hospitals - Commercial/Private Labs - Other End Users Regions Covered:
- North America
o US o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
What our report offers:
- Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements Read the full report: http://www.reportlinker.com/p04823110/Pneumonia-Diagnostic-Global-Market-Outlook.htmlAbout Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.http://www.reportlinker.com__________________________Contact Clare: [email protected]US: (339)-368-6001Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pneumonia-diagnostic---global-market-outlook-2016-2022-300451939.html
SOURCE Reportlinker
